KBC Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
KBC Group's RGEN Position: Q3 2026 in Review
KBC Group held its Repligen (RGEN) position steady in Q3 2026 at 1,837 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #846.
KBC Group first reported a position in RGEN in Q3 2014 and has held it in 27 quarters since. The position peaked at $6.42M in Q3 2023. 287 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- KBC Group held 1,837 shares of Repligen worth $353K as of Q3 2026.
- KBC Group left its Repligen share count unchanged in Q3 2026.
- Repligen made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #846 holding.
- KBC Group first reported a position in Repligen in Q3 2014 and has held it in 27 quarters since.
- KBC Group's Repligen position peaked at $6.42M in Q3 2023.
- 287 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.